Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...
Funding cuts could prevent the FDA from making important recalls like the recent one on Lay's potato chips for undeclared milk allergens, Kevin Thompson, a finance expert and the founder and CEO ...